179 related articles for article (PubMed ID: 38592304)
1. Different Splice Isoforms of Peripheral Triggering Receptor Expressed on Myeloid Cells 2 mRNA Expressions are Associated With Cognitive Decline in Mild Dementia Due to Alzheimer's Disease and Reflect Central Neuroinflammation.
Chiang YK; Lin YS; Chen CY; Lirng JF; Yang YH; Lee WJ; Fuh JL
Am J Alzheimers Dis Other Demen; 2024; 39():15333175241243183. PubMed ID: 38592304
[TBL] [Abstract][Full Text] [Related]
2. Higher Peripheral TREM2 mRNA Levels Relate to Cognitive Deficits and Hippocampal Atrophy in Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
Tan YJ; Ng ASL; Vipin A; Lim JKW; Chander RJ; Ji F; Qiu Y; Ting SKS; Hameed S; Lee TS; Zeng L; Kandiah N; Zhou J
J Alzheimers Dis; 2017; 58(2):413-423. PubMed ID: 28453482
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of TREM2 in peripheral cells from mild cognitive impairment patients who progress into Alzheimer's disease.
Casati M; Ferri E; Gussago C; Mazzola P; Abbate C; Bellelli G; Mari D; Cesari M; Arosio B
Eur J Neurol; 2018 Jun; 25(6):805-810. PubMed ID: 29377401
[TBL] [Abstract][Full Text] [Related]
4. Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer's disease brains.
Ma L; Allen M; Sakae N; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Younkin SG; Sevlever D
Mol Neurodegener; 2016 Nov; 11(1):72. PubMed ID: 27887626
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of TREM2 expression exacerbates neuroinflammatory responses through TLR4-mediated MAPK signaling pathway in a transgenic mouse model of Alzheimer's disease.
Ruganzu JB; Peng X; He Y; Wu X; Zheng Q; Ding B; Lin C; Guo H; Yang Z; Zhang X; Yang W
Mol Immunol; 2022 Feb; 142():22-36. PubMed ID: 34959070
[TBL] [Abstract][Full Text] [Related]
6. TREM2 splice isoforms generate soluble TREM2 species that disrupt long-term potentiation.
Moutinho M; Coronel I; Tsai AP; Di Prisco GV; Pennington T; Atwood BK; Puntambekar SS; Smith DC; Martinez P; Han S; Lee Y; Lasagna-Reeves CA; Lamb BT; Bissel SJ; Nho K; Landreth GE
Genome Med; 2023 Feb; 15(1):11. PubMed ID: 36805764
[TBL] [Abstract][Full Text] [Related]
7. TREM2 ectodomain and its soluble form in Alzheimer's disease.
Yang J; Fu Z; Zhang X; Xiong M; Meng L; Zhang Z
J Neuroinflammation; 2020 Jul; 17(1):204. PubMed ID: 32635934
[TBL] [Abstract][Full Text] [Related]
8. Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study.
Morenas-Rodríguez E; Li Y; Nuscher B; Franzmeier N; Xiong C; Suárez-Calvet M; Fagan AM; Schultz S; Gordon BA; Benzinger TLS; Hassenstab J; McDade E; Feederle R; Karch CM; Schlepckow K; Morris JC; Kleinberger G; Nellgard B; Vöglein J; Blennow K; Zetterberg H; Ewers M; Jucker M; Levin J; Bateman RJ; Haass C;
Lancet Neurol; 2022 Apr; 21(4):329-341. PubMed ID: 35305339
[TBL] [Abstract][Full Text] [Related]
9. The Role of APOE and TREM2 in Alzheimer's Disease-Current Understanding and Perspectives.
Wolfe CM; Fitz NF; Nam KN; Lefterov I; Koldamova R
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30587772
[TBL] [Abstract][Full Text] [Related]
10. The Pathogenesis in Alzheimer's Disease: TREM2 as a Potential Target.
Liu G; Zhang L; Fan Y; Ji W
J Integr Neurosci; 2023 Oct; 22(6):150. PubMed ID: 38176932
[TBL] [Abstract][Full Text] [Related]
11. Triggering receptor expressed on myeloid cells 2 activation downregulates toll-like receptor 4 expression and ameliorates cognitive impairment in the Aβ
Qin Z; Gu M; Zhou J; Zhang W; Zhao N; Lü Y; Yu W
Synapse; 2020 Oct; 74(10):e22161. PubMed ID: 32412103
[TBL] [Abstract][Full Text] [Related]
12. Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease.
Jay TR; Hirsch AM; Broihier ML; Miller CM; Neilson LE; Ransohoff RM; Lamb BT; Landreth GE
J Neurosci; 2017 Jan; 37(3):637-647. PubMed ID: 28100745
[TBL] [Abstract][Full Text] [Related]
13. Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration.
Franzmeier N; Suárez-Calvet M; Frontzkowski L; Moore A; Hohman TJ; Morenas-Rodriguez E; Nuscher B; Shaw L; Trojanowski JQ; Dichgans M; Kleinberger G; Haass C; Ewers M;
Mol Neurodegener; 2020 Oct; 15(1):57. PubMed ID: 33032659
[TBL] [Abstract][Full Text] [Related]
14. Role of trigger receptor 2 expressed on myeloid cells in neuroinflammation－neglected multidimensional regulation of microglia.
Zhang X; Chen X; Zhang L; Sun Y; Liang Y; Li H; Zhang Y
Neurochem Int; 2023 Dec; 171():105639. PubMed ID: 37926352
[TBL] [Abstract][Full Text] [Related]
15. Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge.
Cousins O; Schubert JJ; Chandra A; Veronese M; Valkimadi P; Creese B; Khan Z; Arathimos R; Hampshire A; Rosenzweig I; Ballard C; Corbett A; Aasland D; Velayudhan L; O'Neill M; Collier D; Awais R; Sander K; Årstad E; Howes O; Turkheimer F; Hodges A
J Neuroinflammation; 2023 Nov; 20(1):272. PubMed ID: 37990275
[TBL] [Abstract][Full Text] [Related]
16. TREM2 and the Progression of Alzheimer's Disease.
Gao L; Jiang T; Yao X; Yu L; Yang X; Li Y
Curr Neurovasc Res; 2017; 14(2):177-183. PubMed ID: 28393702
[TBL] [Abstract][Full Text] [Related]
17. Reduced TREM2 activation in microglia of patients with Alzheimer's disease.
Okuzono Y; Sakuma H; Miyakawa S; Ifuku M; Lee J; Das D; Banerjee A; Zhao Y; Yamamoto K; Ando T; Sato S
FEBS Open Bio; 2021 Nov; 11(11):3063-3080. PubMed ID: 34523252
[TBL] [Abstract][Full Text] [Related]
18. The Emerging Roles and Therapeutic Potential of Soluble TREM2 in Alzheimer's Disease.
Zhong L; Chen XF
Front Aging Neurosci; 2019; 11():328. PubMed ID: 32038221
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation changes at TREM2 intron 1 and TREM2 mRNA expression in patients with Alzheimer's disease.
Ozaki Y; Yoshino Y; Yamazaki K; Sao T; Mori Y; Ochi S; Yoshida T; Mori T; Iga JI; Ueno SI
J Psychiatr Res; 2017 Sep; 92():74-80. PubMed ID: 28412600
[TBL] [Abstract][Full Text] [Related]
20. TREM2 overexpression rescues cognitive deficits in APP/PS1 transgenic mice by reducing neuroinflammation via the JAK/STAT/SOCS signaling pathway.
Ruganzu JB; Zheng Q; Wu X; He Y; Peng X; Jin H; Zhou J; Ma R; Ji S; Ma Y; Qian Y; Wang Y; Yang W
Exp Neurol; 2021 Feb; 336():113506. PubMed ID: 33065077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
